ELVN Enliven Therapeutics, Inc. - Common Stock
$58,97
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$15–$62
93% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$72
+22% upside
P/E (TTM)
-32.2
ROE
-21.9%
Nettogewinnmarge
—
ELVN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$58.97
Marktkapitalisierung
$3.51B
P/E (TTM)
-32.2
EPS (TTM)
$-1.83
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-21.9%
Verschuldungsgrad
—
52W-Spanne
$15 – $62
ELVN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-1.83
2021-12-31
→
2025-12-31
Freier Cashflow
$-70M
2020-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ELVN
Peer-Median
P/E (TTM)
-32.2
38.7
P/B (K/B)
7.6
3.8
Price / FCF (Kurs / FCF)
-49.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ELVN
Peer-Median
ROA
-25.9%
-6.4%
ROE
-21.9%
-16.8%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ELVN
Peer-Median
Current Ratio (Liquiditätsgrad)
28.7
12.8
Quick Ratio
27.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ELVN
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ELVN
Peer-Median
ELVN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 7 38,9%
- Kauf 10 55,6%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-17
Median
$70.00
Mittelwert
$72.22
← Unter allen Zielen
$58.97
Tief
$62.00
Hoch
$82.00
Median-Ziel
$70.00
+18,7%
Mittelwert-Ziel
$72.22
+22,5%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.49 | $-0.41 | -0.08% |
| 31. März 2026 | $-0.38 | $-0.47 | 0.09% |
| 31. Dezember 2025 | $-0.48 | $-0.39 | -0.09% |
| 30. September 2025 | $-0.32 | $-0.44 | 0.12% |
| 30. Juni 2025 | $-0.49 | $-0.54 | 0.05% |
| 31. März 2025 | $-0.57 | $-0.51 | -0.06% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| MANE | — | — | — | — | 82.6% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $86M | $81M | $65M | $31M | $38M | $32M | $19M | |
| SG&A Expense | $34M | $24M | $19M | $8M | $13M | $10M | $5M | |
| Operating Expenses | $120M | $105M | $84M | $39M | $51M | $42M | $24M | |
| Operating Income | $-120M | $-105M | $-84M | $-39M | $-51M | $-42M | $-24M | |
| Other Non-op | $-49.0K | $-2.0K | $-22.0K | $0 | $-175.0K | $-145.0K | $75.0K | |
| Pretax Income | · | · | · | $2M | $-51M | · | · | |
| Income Tax | $0 | $232.0K | $0 | $0 | · | · | · | |
| Net Income | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | $-23M | |
| EPS (Basic) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| EPS (Diluted) | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 | · | · | |
| Shares (Basic) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| Shares (Diluted) | 56,664,226 | 47,072,532 | 35,546,215 | 3,124,274 | 21,661,450 | · | · | |
| EBITDA | $-119M | $-104M | $-83M | $730.0K | $-51M | $-42M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $124M | $100M | $76M | $48M | $48M | $5M | |
| Short-term Investments | $364M | $189M | $153M | $0 | · | · | · | |
| Prepaid Expense | $12M | $5M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $475M | $318M | $266M | $78M | $93M | $90M | $31M | |
| PP&E (Net) | $34.0K | $458.0K | $742.0K | $890.0K | $250.0K | $349.0K | $442.0K | |
| PP&E (Gross) | $263.0K | $1M | $1M | $1M | $479.0K | $479.0K | $475.0K | |
| Accum. Depreciation | $229.0K | $919.0K | $671.0K | $374.0K | $229.0K | $130.0K | $33.0K | |
| Other Non-current Assets | $656.0K | $7M | $4M | $0 | $175.0K | $88.0K | $2M | |
| Total Assets | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Accounts Payable | $2M | $1M | $532.0K | $3M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | $2M | $5M | $4M | $3M | |
| Current Liabilities | $17M | $16M | $26M | $10M | $7M | $6M | $4M | |
| Capital Leases | $0 | · | $0 | · | $406.0K | · | · | |
| Other Non-current Liabilities | $0 | $0 | $67.0K | $659.0K | · | · | · | |
| Total Liabilities | $17M | $16M | $26M | $10M | $8M | $6M | $4M | |
| Common Stock | $59.0K | $49.0K | $41.0K | $1.0K | $27.0K | $18.0K | $1.0K | |
| Paid-in Capital | $806M | $553M | $400M | $6M | $234M | $181M | $6M | |
| Retained Earnings | $-347M | $-243M | $-154M | $-83M | $-147M | $-96M | $-55M | |
| AOCI | $334.0K | $55.0K | $141.0K | $0 | $-16.0K | $4.0K | $32.0K | |
| Stockholders' Equity | $460M | $310M | $246M | $-77M | $-43M | $84M | $-49M | |
| Liabilities + Equity | $476M | $326M | $272M | $83M | $94M | $91M | $33M | |
| Shares Outstanding | 59,440,045 | 48,936,459 | 41,292,027 | 3,570,019 | 26,287,264 | 17,548,263 | 702,510 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $300.0K | $300.0K | $300.0K | $200.0K | · | · | · | |
| Stock-based Comp | $34M | $20M | $13M | $3M | $4M | $2M | $899.0K | |
| Other Non-cash | $-926.0K | $-5M | $-3M | · | · | · | · | |
| Operating Cash Flow | $-70M | $-73M | $-61M | $-32M | $-47M | $-37M | $-22M | |
| CapEx | $158.0K | $44.0K | $149.0K | $612.0K | $12.0K | $18.0K | $140.0K | |
| Investing Cash Flow | $-174M | $-36M | $-148M | $-612.0K | $-2M | $-17M | $-24M | |
| Stock Issued | · | $0 | $161M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $161M | · | · | · | · | |
| Financing Cash Flow | $219M | $133M | $234M | $-2M | $49M | $97M | $44M | |
| Taxes Paid | $0 | $209.0K | · | · | · | · | · | |
| Free Cash Flow | $-70M | $-73M | $-61M | $-36M | $-47M | $-37M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -25.9% | -29.8% | -40.3% | 1.6% | -55.7% | -66.6% | · | |
| ROE | -21.9% | -29.8% | -28.2% | 13.5% | -55.4% | -46.2% | · | |
| ROIC | · | · | · | 0.76% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 | 14.5 | · | |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 | 7.6 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-104M | $-89M | $-72M | $-38M | $-51M | $-41M | · | |
| Market Cap | $915M | $1.10B | $571M | $430M | $237M | $1.55B | · | |
| P/E | -8.4 | -11.9 | -6.9 | -1.4 | -3.8 | · | · | |
| P/B | 2.0 | 3.6 | 2.3 | 4.8 | 2.8 | 18.3 | · | |
| P / Tangible Book | 2.0 | 3.6 | 2.3 | · | · | 18.3 | · | |
| P / Cash Flow | -13.0 | -15.0 | -9.3 | -12.1 | -5.1 | -41.4 | · | |
| P / FCF | -13.0 | -15.0 | -9.3 | -12.0 | -5.1 | -41.4 | · | |
| Earnings Yield | -11.9% | -8.4% | -14.5% | -73.7% | -26.3% | · | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $21M | $21M | $18M | $21M | $25M | $21M | $21M | $19M | $20M | $18M | $20M | $15M | $12M | $8M | $8M | |
| SG&A Expense | $8M | $7M | $13M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $2M | $3M | |
| Operating Expenses | $37M | $28M | $34M | $25M | $29M | $32M | $27M | $27M | $25M | $26M | $23M | $24M | $20M | $16M | $10M | $11M | |
| Operating Income | $-37M | $-28M | $-34M | $-25M | $-29M | $-32M | $-27M | $-27M | $-25M | $-26M | $-23M | $-24M | $-20M | $-16M | $-10M | $-11M | |
| Other Non-op | $-8.0K | $0 | $0 | $0 | $-2.0K | $-47.0K | $0 | $0 | $-1.0K | $-1.0K | $-9.0K | $-13.0K | $0 | $0 | $-136.0K | $0 | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $232.0K | · | $0 | $0 | · | · | · | · | |
| Net Income | $-32M | $-24M | $-30M | $-20M | $-25M | $-29M | $-23M | $-23M | $-20M | $-23M | $-19M | $-21M | $-17M | $-15M | $-10M | $-11M | |
| EPS (Basic) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| EPS (Diluted) | $-0.49 | $-0.38 | $-0.45 | $-0.32 | $-0.49 | $-0.57 | $-0.46 | $-0.48 | $-0.41 | $-0.54 | $-0.29 | $-0.51 | $-0.41 | $-0.80 | $-2.91 | $-3.27 | |
| Shares (Basic) | 66,171,581 | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | |
| Shares (Diluted) | 66,171,581 | 62,799,326 | -107,585,904 | 62,093,795 | 52,105,052 | 50,051,283 | -91,315,569 | 48,267,458 | 48,075,035 | 42,045,608 | -87,406,707 | 41,030,874 | 40,961,024 | 40,961,024 | -6,085,171 | 3,228,692 | |
| EBITDA | $-37M | $-28M | · | $-25M | $-29M | $-32M | · | $-27M | $-25M | $-26M | · | $-24M | $-20M | $51M | · | $-5M |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $132M | $99M | $102M | $119M | $102M | $124M | $101M | $97M | $149M | $100M | $74M | $126M | $292M | $76M | $49M | |
| Short-term Investments | $760M | $320M | $364M | $376M | $371M | $188M | $189M | $191M | $216M | $171M | $153M | $190M | $152M | · | $0 | · | |
| Prepaid Expense | $12M | $11M | $12M | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $3M | $5M | $5M | $6M | $2M | $3M | |
| Current Assets | $907M | $463M | $475M | $483M | $496M | $294M | $318M | $297M | $318M | $337M | $266M | $269M | $283M | $298M | $78M | $59M | |
| PP&E (Net) | $140.0K | $20.0K | $34.0K | $399.0K | $462.0K | $404.0K | $458.0K | $549.0K | $630.0K | $683.0K | $742.0K | $806.0K | $867.0K | $853.0K | $890.0K | · | |
| PP&E (Gross) | $390.0K | · | $263.0K | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | |
| Accum. Depreciation | $250.0K | $243.0K | $229.0K | $1M | $1M | $993.0K | $919.0K | $908.0K | $828.0K | $750.0K | $671.0K | $593.0K | $515.0K | $441.0K | $374.0K | · | |
| Other Non-current Assets | $1M | $1M | $656.0K | $7M | $7M | $7M | $7M | $7M | $8M | $4M | $4M | $4M | $3M | $3M | $0 | · | |
| Total Assets | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Accounts Payable | $371.0K | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | $3M | $532.0K | $1M | $3M | $6M | $3M | $767.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $14M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $9M | $11M | $10M | $2M | |
| Capital Leases | $913.0K | $0 | $0 | $103.0K | $204.0K | $302.0K | · | $0 | $0 | $0 | · | $81.0K | $162.0K | $242.0K | · | · | |
| Other Non-current Liabilities | $913.0K | · | · | $103.0K | $204.0K | $302.0K | · | $0 | $6.0K | $34.0K | $67.0K | $214.0K | $360.0K | $508.0K | $659.0K | · | |
| Total Liabilities | $15M | $11M | $17M | $15M | $15M | $14M | $16M | $17M | $22M | $25M | $26M | $12M | $10M | $11M | $10M | $2M | |
| Common Stock | $73.0K | $61.0K | $59.0K | $59.0K | $59.0K | $49.0K | $49.0K | $47.0K | $47.0K | $47.0K | $41.0K | $41.0K | $41.0K | $41.0K | $1.0K | $27.0K | |
| Paid-in Capital | $1.30B | $824M | $806M | $793M | $786M | $560M | $553M | $508M | $502M | $495M | $400M | $397M | $393M | $389M | $6M | $235M | |
| Retained Earnings | $-403M | $-371M | $-347M | $-317M | $-297M | $-272M | $-243M | $-220M | $-197M | $-177M | $-154M | $-135M | $-114M | $-98M | $-83M | $-178M | |
| AOCI | $-2M | $-382.0K | $334.0K | $221.0K | $-177.0K | $-16.0K | $55.0K | $242.0K | $-139.0K | $-53.0K | $141.0K | $-147.0K | $-111.0K | · | $0 | $-4.0K | |
| Stockholders' Equity | $895M | $453M | $460M | $476M | $488M | $288M | $310M | $288M | $305M | $318M | $246M | $262M | $279M | $291M | $-77M | $57M | |
| Liabilities + Equity | $910M | $465M | $476M | $491M | $504M | $303M | $326M | $305M | $327M | $343M | $272M | $274M | $289M | $303M | $83M | $59M | |
| Shares Outstanding | 73,251,648 | 60,889,655 | 59,440,045 | 59,261,286 | 59,226,171 | 49,038,730 | 48,936,459 | 47,254,280 | 47,173,466 | 46,782,639 | 41,292,027 | 41,204,973 | 41,151,111 | 41,106,277 | 3,570,019 | 26,287,264 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.0K | $14.0K | $83.0K | $62.0K | $81.0K | $74.0K | $62.0K | $80.0K | $79.0K | $79.0K | $80.0K | $79.0K | $74.0K | $67.0K | $-39M | $60.0K | |
| Stock-based Comp | $14M | $7M | $12M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | $3M | $4M | $2M | $735.0K | $1M | |
| Other Non-cash | · | $-3M | · | · | · | $-2M | · | · | · | $-5M | · | · | · | $-75M | · | · | |
| Operating Cash Flow | $-19M | $-19M | $-16M | $-13M | $-17M | $-24M | $-17M | $-12M | $-20M | $-23M | $-12M | $-16M | $-12M | $-21M | $-8M | $6M | |
| CapEx | $99.0K | $0 | $0 | $-1.0K | $139.0K | $20.0K | $0 | $22.0K | $2.0K | $20.0K | $14.0K | $16.0K | $88.0K | $31.0K | $101.0K | $169.0K | |
| Investing Cash Flow | $-442M | $43M | $12M | $-4M | $-184M | $1M | $727.0K | $15M | $-34M | $-18M | $39M | $-36M | $-152M | $-31.0K | $-101.0K | $-12M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-2M | $163M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $163M | · | · | |
| Financing Cash Flow | $463M | $10M | $623.0K | $-368.0K | $218M | $234.0K | $40M | $1M | $2M | $90M | $90.0K | $-425.0K | $-3M | $237M | $-2M | $164.0K | |
| Taxes Paid | · | · | $0 | · | · | · | $-23.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-19M | · | · | · | $-24M | · | · | · | $-23M | · | · | · | $-21M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -4.6% | -6.2% | · | -5.1% | -6.1% | -8.8% | · | -8.0% | -6.5% | -7.0% | · | -12.5% | -9.5% | -7.7% | · | -5.5% | |
| ROE | -4.7% | -6.4% | · | -5.3% | -6.4% | -9.4% | · | -8.4% | -6.8% | -7.5% | · | -13.0% | -9.8% | -8.1% | · | -5.9% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 64.1 | 40.3 | · | 32.9 | 32.6 | 21.1 | · | 17.4 | 14.4 | 13.5 | · | 22.2 | 31.0 | 27.2 | · | 32.5 | |
| Quick Ratio | 63.2 | 39.4 | · | 32.6 | 32.2 | 20.7 | · | 17.1 | 14.1 | 12.8 | · | 21.8 | 30.4 | 26.7 | · | 27.2 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-102M | $-98M | · | $-97M | $-97M | $-94M | · | $-87M | $-80M | $-75M | · | $-63M | $-51M | $-43M | · | $-42M | |
| Market Cap | $3.72B | $2.39B | · | $1.21B | $1.19B | $965M | · | $1.21B | $1.10B | $823M | · | $563M | $840M | $900M | · | $240M | |
| P/E | -30.2 | -22.3 | · | -11.0 | -10.3 | -9.8 | · | -13.2 | -12.5 | -7.8 | · | -2.7 | -2.8 | -2.2 | · | -0.9 | |
| P/B | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Tangible Book | 4.2 | 5.3 | · | 2.5 | 2.4 | 3.3 | · | 4.2 | 3.6 | 2.6 | · | 2.2 | 3.0 | 3.1 | · | 4.2 | |
| P / Cash Flow | · | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.2 | · | · | |
| P / FCF | · | -123.7 | · | · | · | -40.0 | · | · | · | -35.2 | · | · | · | -43.1 | · | · | |
| Earnings Yield | -3.3% | -4.5% | · | -9.1% | -9.7% | -10.2% | · | -7.6% | -8.0% | -12.8% | · | -36.5% | -36.0% | -45.4% | · | -108.3% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-104M | $-89M | $-72M | $-38M | $-51M |
| Verwässerte EPS | $-1.83 | $-1.89 | $-2.01 | $-12.05 | $-2.37 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 28.7 | 20.0 | 10.3 | 49.0 | 12.9 |
| Quick Ratio | 27.9 | 19.7 | 9.8 | 48.2 | 6.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-70M | $-73M | $-61M | $-36M | $-47M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 221 Einreicher · $3.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 62 (-10 vs. Vorquartal) | 15 (0 vs. Vorquartal) | 77 (+19 vs. Vorquartal) | 51 (+18 vs. Vorquartal) | +12.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $449.607.902 | 8.859.269 | 13,25% | Aktien |
| ORBIMED ADVISORS LLC | $343.914.074 | 6.776.632 | 10,13% | Aktien |
| Polar Capital Holdings Plc | $326.354.777 | 6.430.636 | 9,62% | Aktien |
| Vestal Point Capital, LP | $203.000.000 | 4.000.000 | 5,98% | Aktien |
| Commodore Capital LP | $166.206.250 | 3.275.000 | 4,90% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $130.376.852 | 2.569.002 | 3,84% | Aktien |
| CITADEL ADVISORS LLC | $101.874.840 | 2.007.386 | 3,00% | Aktien |
| Fairmount Funds Management LLC | $94.173.933 | 1.855.644 | 2,78% | Aktien |
| Siren, L.L.C. | $90.051.358 | 1.774.411 | 2,65% | Aktien |
| Bellevue Group AG | $75.617.500 | 1.490.000 | 2,23% | Aktien |
| First Light Asset Management, LLC | $69.058.063 | 1.360.750 | 2,04% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $62.098.160 | 1.223.306 | 1,83% | Aktien |
| STATE STREET CORP | $61.591.012 | 1.213.616 | 1,82% | Aktien |
| Pictet Asset Management Holding SA | $58.960.538 | 1.161.784 | 1,74% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $54.978.135 | 1.083.313 | 1,62% | Aktien |
| NOVO HOLDINGS A/S | $50.750.000 | 1.000.000 | 1,50% | Aktien |
| First Turn Management, LLC | $48.433.770 | 954.360 | 1,43% | Aktien |
| BAKER BROS. ADVISORS LP | $45.938.443 | 905.191 | 1,35% | Aktien |
| Candriam S.C.A. | $45.918.733 | 905.674 | 1,35% | Aktien |
| Tri Locum Partners LP | $43.985.837 | 866.716 | 1,30% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $35.129.511 | 896.161 | 1,04% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $31.686.828 | 624.371 | 0,93% | Aktien |
| Balyasny Asset Management L.P. | $30.814.842 | 607.189 | 0,91% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $28.732.976 | 566.165 | 0,85% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28.560.222 | 562.763 | 0,84% | Aktien |
| Avidity Partners Management LP | $27.912.500 | 550.000 | 0,82% | Aktien |
| MARSHALL WACE, LLP | $26.713.227 | 526.369 | 0,79% | Aktien |
| Venrock Adviser, LLC | $26.711.298 | 526.331 | 0,79% | Aktien |
| Affinity Asset Advisors, LLC | $25.375.000 | 500.000 | 0,75% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $24.836.137 | 489.382 | 0,73% | Aktien |
| Logos Global Management LP | $23.598.750 | 465.000 | 0,70% | Aktien |
| Rock Springs Capital Management LP | $23.579.719 | 464.625 | 0,69% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21.540.330 | 424.440 | 0,63% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $20.876.622 | 411.362 | 0,62% | Aktien |
| Nicholas Investment Partners, LP | $19.870.097 | 391.529 | 0,59% | Aktien |
| ADAR1 Capital Management, LLC | $19.676.689 | 387.718 | 0,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $19.462.118 | 383.490 | 0,57% | Aktien |
| SAMLYN CAPITAL, LLC | $17.678.966 | 348.354 | 0,52% | Aktien |
| Woodline Partners LP | $17.617.457 | 347.142 | 0,52% | Aktien |
| STEMPOINT CAPITAL LP | $17.605.886 | 346.914 | 0,52% | Aktien |
| Spruce Street Capital LP | $16.697.055 | 329.006 | 0,49% | Aktien |
| Longaeva Partners L.P. | $15.862.420 | 312.560 | 0,47% | Aktien |
| JENNISON ASSOCIATES LLC | $15.692.866 | 309.219 | 0,46% | Aktien |
| Assenagon Asset Management S.A. | $15.558.631 | 306.574 | 0,46% | Aktien |
| D. E. Shaw & Co., Inc. | $15.514.427 | 305.703 | 0,46% | Aktien |
| Seven Fleet Capital Management LP | $14.673.652 | 289.136 | 0,43% | Aktien |
| GOLDMAN SACHS GROUP INC | $14.142.655 | 278.673 | 0,42% | Aktien |
| AMERIPRISE FINANCIAL INC | $12.518.808 | 246.676 | 0,37% | Aktien |
| Deep Track Capital, LP | $11.418.750 | 225.000 | 0,34% | Aktien |
| Blackstone Inc. | $10.949.008 | 215.744 | 0,32% | Aktien |
| Patient Square Capital LP | $10.784.375 | 212.500 | 0,32% | Aktien |
| Soleus Capital Management, L.P. | $8.408.108 | 165.677 | 0,25% | Aktien |
| Squadron Capital Management LLC | $8.120.000 | 160.000 | 0,24% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $8.044.992 | 158.522 | 0,24% | Aktien |
| Integral Health Asset Management, LLC | $7.612.500 | 150.000 | 0,22% | Aktien |
| Cormorant Asset Management, LP | $7.612.500 | 150.000 | 0,22% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $7.131.187 | 140.516 | 0,21% | Aktien |
| HighVista Strategies LLC | $6.996.700 | 137.866 | 0,21% | Aktien |
| Eversept Partners, LP | $6.934.023 | 136.631 | 0,20% | Aktien |
| Ikarian Capital, LLC | $6.421.957 | 126.541 | 0,19% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $5.722.824 | 112.765 | 0,17% | Aktien |
| J. Goldman & Co LP | $5.690.547 | 112.129 | 0,17% | Aktien |
| TD Asset Management Inc | $5.569.204 | 109.738 | 0,16% | Aktien |
| Cinctive Capital Management LP | $5.465.166 | 107.688 | 0,16% | Aktien |
| Exome Asset Management LLC | $5.085.302 | 100.203 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.892.300 | 96.400 | 0,14% | Kaufoption |
| Swiss National Bank | $4.799.580 | 94.573 | 0,14% | Aktien |
| VANGUARD GROUP INC | $4.679.767 | 303.881 | 0,14% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.977.531 | 78.375 | 0,12% | Aktien |
| DV EQUITIES, LLC | $3.869.688 | 76.250 | 0,11% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.819.699 | 75.265 | 0,11% | Aktien |
| Artia Global Partners LP | $3.659.075 | 72.100 | 0,11% | Aktien |
| ALGERT GLOBAL LLC | $3.658.568 | 72.090 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $3.654.000 | 72.000 | 0,11% | Verkaufsoption |
| Informed Momentum Co LLC | $3.574.424 | 70.432 | 0,11% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $3.552.500 | 70.000 | 0,10% | Aktien |
| GREAT POINT PARTNERS LLC | $3.552.500 | 70.000 | 0,10% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.407.913 | 67.151 | 0,10% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $3.307.581 | 65.174 | 0,10% | Aktien |
| BlackRock, Inc. | $3.106.306 | 61.208 | 0,09% | Aktien |
| RHUMBLINE ADVISERS | $2.904.972 | 57.241 | 0,09% | Aktien |
| Schonfeld Strategic Advisors LLC | $2.836.112 | 55.884 | 0,08% | Aktien |
| Atom Investors LP | $2.543.692 | 50.122 | 0,07% | Aktien |
| Caption Management, LLC | $2.537.500 | 50.000 | 0,07% | Kaufoption |
| Jones Hill Capital LP | $2.529.888 | 49.850 | 0,07% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $2.318.514 | 45.685 | 0,07% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $2.035.989 | 40.118 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.983.259 | 39.079 | 0,06% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.980.823 | 39.031 | 0,06% | Aktien |
| JANE STREET GROUP, LLC | $1.908.200 | 37.600 | 0,06% | Kaufoption |
| Trexquant Investment LP | $1.902.668 | 37.491 | 0,06% | Aktien |
| Bank of New York Mellon Corp | $1.766.658 | 34.811 | 0,05% | Aktien |
| TimesSquare Capital Management, LLC | $1.764.000 | 45.000 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.696.674 | 33.432 | 0,05% | Aktien |
| Ishara Investments LP | $1.664.600 | 32.800 | 0,05% | Aktien |
| Brevan Howard Capital Management LP | $1.660.439 | 32.718 | 0,05% | Aktien |
| Engineers Gate Manager LP | $1.479.464 | 29.152 | 0,04% | Aktien |
| CITIGROUP INC | $1.433.180 | 28.240 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $1.361.775 | 26.833 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $1.344.875 | 26.500 | 0,04% | Verkaufsoption |
Unternehmensinsider 28 Insider · 7 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Samuel Kintz | President and CEO | 25. Januar 2024 M | 0 | 0 | 0 | $0 |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | 17. Juli 2026 M | 46.054 | 0 | 8 | $-580.338 |
| Michael Gray | CFO & COO | 22. Februar 2023 S | 27.610 | 0 | 0 | $0 |
| Anish Patel | Chief Operating Officer | 22. Januar 2024 S | 17.222 | 0 | 0 | $0 |
| Helen Louise Collins | CHIEF MEDICAL OFFICER | 17. Juli 2026 M | 25.000 | 0 | 8 | $-482.386 |
| Joseph P Lyssikatos | Chief Scientific Officer | 29. Dezember 2023 M | 0 | 0 | 0 | $0 |
| Kenneth Attie | SVP, CMO | 28. Januar 2022 A | 34.100 | 0 | 0 | $0 |
| Lori Anne Kunkel | Direktor | 6. Juli 2026 S | 41.884 | 0 | 3 | $-771.524 |
| Rishi Gupta | Direktor | 16. Mai 2024 S | 7.663.349 | 0 | 0 | $0 |
| Richard A. Heyman | Direktor | 22. Dezember 2023 S | 29.216 | 0 | 0 | $0 |
| Andrew John Phillips | Direktor | 23. Februar 2023 A | — | 0 | 0 | $0 |
| Rahul D. Ballal | Direktor | 23. Februar 2023 A | 87.835 | 0 | 0 | $0 |
| Jake Bauer | Direktor | 23. Februar 2023 A | 87.372 | 0 | 0 | $0 |
| Andrew J. Schwab | Direktor | 23. Februar 2023 A | 960.383 | 0 | 0 | $0 |
| Laura A Williams | Direktor | 2. Juni 2022 A | — | 0 | 0 | $0 |
| Mark Chin | Direktor | 2. Juni 2022 A | 2.344.072 | 0 | 0 | $0 |
| Edward R. Conner | Direktor | 2. Juni 2022 A | — | 0 | 0 | $0 |
| Barbara Dalton | Direktor | 2. Juni 2022 A | 1.557.722 | 0 | 0 | $0 |
| David P Bonita | Direktor | 2. Juni 2022 A | 4.199.068 | 0 | 0 | $0 |
| David M Mott | Direktor | 2. Juni 2022 A | 229.224 | 0 | 0 | $0 |
| Carl Goldfischer | Direktor | 2. Juni 2022 A | — | 0 | 0 | $0 |
| James G Mcarthur | Direktor | 16. März 2020 A | — | 0 | 0 | $0 |
| Mette Kirstine Agger | Direktor | 16. März 2020 A | 1.432.722 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10%-Eigentümer | 16. März 2020 C | 293.013 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10%-Eigentümer | 16. März 2020 C | 1.432.722 | 0 | 0 | $0 |
| H LUNDBECK A S | 10%-Eigentümer | 16. März 2020 C | 522.499 | 0 | 0 | $0 |
| Mika K Derynck | — | 4. August 2026 M | 0 | 0 | 1 | $-9.561.047 |
| Sara M. Nayeem | — | 29. Juni 2021 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, ORBIMED GENESIS GP LLC, ORBIMED CAPITAL LLC ×7 Einreichungen | 24. Juni 2026 | 9,50% | Änderung | — | SEC |
| 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab ×5 Einreichungen | 29. Juli 2024 | — | Erste Einreichung | — | SEC |
| 5AM Partners VI, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Kush Parmar, Andrew J. Schwab | 6. März 2023 | — | Erste Einreichung | Passive Anlage | SEC |
| 24. Mai 2022 | — | Erste Einreichung | — | SEC | |
| New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Scott D. Sandell, Peter W. Sonsini ×3 Einreichungen | 25. April 2022 | — | Erste Einreichung | Passive Anlage | SEC |
| Arix Bioscience Plc, Arix Bioscience Holdings Limited, Mark Chin ×3 Einreichungen | 20. Juli 2021 | — | Erste Einreichung | — | SEC |
| Arix Bioscience Plc (2), Arix Bioscience Holdings Limited (2), Mark Chin (1) (2) | 24. März 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 48 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,81% | 16.370 NS | 30. April 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 73.604 SH | 8. August 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,80% | 5.620 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 1,31% | 58.197 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,03% | 10.703 NS | 31. Mai 2026 | N-PORT |
| IHE · iShares Trust | 0,72% | 194.624 SH | 8. August 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,51% | 38.057 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,26% | 407.872 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,25% | 3.315 SH | 8. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,23% | 1.424 NS | 30. April 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,16% | 51.358 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,16% | 388.661 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 45.928 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 47.349 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,12% | 2.196 NS | 31. Mai 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,11% | 34.350 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 61.669 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 1.094.617 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,07% | 12.024 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 246.533 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 33.580 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,05% | 2.494 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,05% | 175.955 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 141.971 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,04% | 1.852 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 214.005 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,03% | 3.976 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 624.513 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 2.892 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 1.449 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 14.804 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 8.632 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 1.465 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.649 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 22.815 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 37 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.666 NS | 30. April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 569 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 66.943 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 12.036 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 14.379 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 7.755 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 30.821 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 28.939 NS | 30. April 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 154 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 691 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.883.832 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.533 SH | 8. August 2026 | Täglich |